Literature DB >> 8408648

Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells.

M Sakai1, K Eguchi, K Terada, M Nakashima, I Yamashita, H Ida, Y Kawabe, T Aoyagi, H Takino, T Nakamura.   

Abstract

The present study was performed to clarify the relationship between human T cell lymphotropic virus type I (HTLV-I) infection and chronic inflammatory arthropathy. To determine the ability of HTLV-I to infect synovial cells and the effect on synovial cell proliferation, synovial cells were cocultured with the HTLV-I-producing T cell lines (MT-2 or HCT-1). After coculture with HTLV-I-infected T cells, the synovial cells expressed HTLV-I-specific core antigens, and HTLV-I proviral DNA was detected from the synovial cells by polymerase chain reaction. These cocultured synovial cells with HTLV-I-infected T cells proliferated more actively than the synovial cells cocultured with uninfected T cells. This stimulatory effect of HTLV-I-infected T cells on synovial cell proliferation seems necessary to contact each other. After being cocultured with MT-2 cells, synovial cells proliferated more actively than control cells even after several passages. Furthermore, HTLV-I-infected synovial cells produced significant amounts of granulocyte/macrophage colony-stimulating factor. These results suggest that HTLV-I can infect synovial cells, resulting their active proliferation and may be involved in the pathogenesis of proliferative synovitis similar to that found in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408648      PMCID: PMC288362          DOI: 10.1172/JCI116789

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

2.  Infection of human endothelial cells by human T-lymphotropic virus type I.

Authors:  D D Ho; T R Rota; M S Hirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

3.  Adult T-cell leukemia (ATL) virus-specific antibodies in ATL patients and healthy virus carriers.

Authors:  N Yamamoto; J Schneider; Y Koyanagi; Y Hinuma; G Hunsmann
Journal:  Int J Cancer       Date:  1983-09-15       Impact factor: 7.396

4.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

5.  Isolation of HTLV derived from Japanese adult T-cell leukemia patients in human diploid fibroblast strain IMR90 and the biological characters of the infected cells.

Authors:  H Yoshikura; J Nishida; M Yoshida; Y Kitamura; F Takaku; S Ikeda
Journal:  Int J Cancer       Date:  1984-06-15       Impact factor: 7.396

6.  Infection of human endothelial cells by human T-cell leukemia virus type I.

Authors:  J A Hoxie; D M Matthews; D B Cines
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

7.  Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor.

Authors:  R Munker; J Gasson; M Ogawa; H P Koeffler
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

8.  Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2.

Authors:  J R Zucali; C A Dinarello; D J Oblon; M A Gross; L Anderson; R S Weiner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

9.  Fibroblast growth factors released by wounded endothelial cells stimulate proliferation of synovial cells.

Authors:  K Eguchi; K Migita; M Nakashima; H Ida; K Terada; M Sakai; A Kawakami; T Aoyagi; T Ishimaru; S Nagataki
Journal:  J Rheumatol       Date:  1992-12       Impact factor: 4.666

10.  The x gene is essential for HTLV replication.

Authors:  I S Chen; D J Slamon; J D Rosenblatt; N P Shah; S G Quan; W Wachsman
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

View more
  14 in total

1.  Treatment for HTLV-I associated arthropathy: a case study and synovial tissue culture analysis.

Authors:  Toshiaki Takahashi; Shigeki Takemoto; Katsuhito Kiyasu; Hiroshi Yamamoto; Toshikazu Tani; Isamu Miyoshi; Hirokuni Taguchi; Toshiaki Moriki; Emiko Miyazaki; Hideaki Enzan
Journal:  Rheumatol Int       Date:  2005-07-01       Impact factor: 2.631

2.  HTLV-1 targets human placental trophoblasts in seropositive pregnant women.

Authors:  Kenta Tezuka; Naoki Fuchi; Kazu Okuma; Takashi Tsukiyama; Shoko Miura; Yuri Hasegawa; Ai Nagata; Nahoko Komatsu; Hiroo Hasegawa; Daisuke Sasaki; Eita Sasaki; Takuo Mizukami; Madoka Kuramitsu; Sahoko Matsuoka; Katsunori Yanagihara; Kiyonori Miura; Isao Hamaguchi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

3.  HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.

Authors:  S Okazaki; R Moriuchi; N Yosizuka; K Sugahara; T Maeda; I Jinnai; M Tomonaga; S Kamihira; S Katamine
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

4.  Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I.

Authors:  H Takashima; K Eguchi; A Kawakami; Y Kawabe; K Migita; M Sakai; T Origuchi; S Nagataki
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

5.  Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals.

Authors:  Y Higashiyama; S Katamine; S Kohno; H Mukae; S Hino; T Miyamoto; K Hara
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

6.  The Association of Increase of Human T-Cell Leukemia Virus Type-1 (HTLV-1) Proviral Load (PVL) With Infection in HTLV-1-Positive Patients With Rheumatoid Arthritis: A Longitudinal Analysis of Changes in HTLV-1 PVLs in a Single Center Cohort Study.

Authors:  Naoki Iwamoto; Takeshi Araki; Ayaka Umetsu; Ayuko Takatani; Toshiyuki Aramaki; Kunihiro Ichinose; Kaoru Terada; Naoyuki Hirakata; Yukitaka Ueki; Atsushi Kawakami; Katsumi Eguchi
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

7.  Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis.

Authors:  S Wakisaka; N Suzuki; M Takeno; Y Takeba; H Nagafuchi; N Saito; H Hashimoto; T Tomita; T Ochi; T Sakane
Journal:  Ann Rheum Dis       Date:  1998-08       Impact factor: 19.103

8.  Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules.

Authors:  Hiromitsu Teruya; Mariko Tomita; Masachika Senba; Chie Ishikawa; Maki Tamayose; Akiko Miyazato; Satomi Yara; Yuetsu Tanaka; Yoichiro Iwakura; Jiro Fujita; Naoki Mori
Journal:  Retrovirology       Date:  2008-09-22       Impact factor: 4.602

9.  Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease.

Authors:  Maria Yakova; Agnès Lézin; Fabienne Dantin; Gisèle Lagathu; Stéphane Olindo; Georges Jean-Baptiste; Serge Arfi; Raymond Césaire
Journal:  Retrovirology       Date:  2005-02-01       Impact factor: 4.602

10.  Association of human T-cell leukemia virus type 1 with prevalent rheumatoid arthritis among atomic bomb survivors: A cross-sectional study.

Authors:  Ayumi Hida; Misa Imaizumi; Benjamin French; Waka Ohishi; Daisuke Haruta; Katsumi Eguchi; Hideki Nakamura; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.